Nootech Biotech: Announcement on voluntary disclosure that a subsidiary has passed an on-site inspection by the US FDA
Nootai Biotech: Notice on Voluntary Disclosure of Drugs Passed GMP Site Inspection
Nootech Biotech: Announcement on voluntary disclosure of drugs that have passed GMP on-site inspections
Nootai Biotech: Notice on Voluntary Disclosure of Ezemebuatorvastatin Calcium Tablets Obtaining Drug Registration Certificates
Nootech Biotech: Notice on Voluntary Disclosure of Ezemab atorvastatin Calcium Tablets Obtaining Drug Registration Certificates
NOTEC Biotech: NOTEC Biotech: Announcement of Resolutions of the 21st Meeting of the 3rd Board of Supervisors
Nootai Biotech: Notice on applying for comprehensive credit lines and providing guarantees from banks
Nootech: Nootech: Announcement on the forecast for daily related transactions in 2025
Nootai Biotech: Notice on Using Idle Raised Funds to Temporarily Replenish Liquidity
Nootech Biotech: Nanjing Securities Co., Ltd.\'s inspection opinion on the use of idle capital raised by Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd. to temporarily supplement working capital
Nootech Biotech: Nanjing Securities Co., Ltd.\'s inspection opinion on the use of temporary idle funds raised by Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd. for cash management
Nootai Biotech: Nootai Biotech: Basic information on the guarantors and the latest financial statements
Nootech Biotech: Nanjing Securities Co., Ltd.\'s inspection opinions on the expected daily transactions of Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd. in 2025
Nootech: Nootai Biotech: Announcement on the use of temporarily idle funds raised for cash management
Nootech: Announcement on Using Idle Raised Funds to Temporarily Replenish Liquidity
Nootai Biotech: Announcement on the use of temporarily idle funds raised for cash management
Nootech Biotech: Announcement on applying for comprehensive credit lines and providing guarantees from banks
Nanjing Securities Co., Ltd. inspection opinions on the use of idle funds raised by Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd. to temporarily supplement working capital
Nootech: Announcement on the forecast for daily related transactions in 2025
Nanjing Securities Co., Ltd. inspection opinions on the use of temporary idle funds raised by Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd. for cash management